Skip to main content
Home
Toggle menu

Give Now

  • For Patients
  • School Of Medicine
  • About
    • Leadership
    • Department Directory
    • News
    • Events
    • Annual Report
    • Nashville
  • Divisions
    • Allergy, Pulmonary and Critical Care Medicine
    • Cardiovascular Medicine
    • Diabetes, Endocrinology and Metabolism
    • Epidemiology
    • Gastroenterology, Hepatology and Nutrition
    • General Internal Medicine and Public Health
    • Genetic Medicine and Clinical Pharmacology
    • Geriatric Medicine
    • Hematology and Oncology
    • Infectious Diseases
    • Nephrology and Hypertension
    • Rheumatology and Immunology
  • Education
    • Overview
    • Internal Medicine Residency Program
    • Physician-Scientist Training Program
    • Internal Medicine-Pediatrics Residency Program
    • Fellowship Programs
    • EXCellence In TEaching Pathway
    • Physician-Scientist Doctoral Program
    • Medical Students
    • Alumni
    • Medicine Grand Rounds
  • Research
    • Overview
    • Clinical Trials
    • Publications
    • Research Centers and Labs
  • Faculty
    • Open Faculty Positions
    • Professional Development
  • Clinical Initiatives
    • Digital Health
    • Physician Builder Program

User Detail

Patricia Yancey, PhD

Research Assistant Professor of Medicine

Division of Cardiovascular Medicine
Patricia Yancey
Professional Bio
Patricia Yancey, PhD, is a Research Assistant Professor in the Division of Cardiovascular Medicine in the Department of Medicine at Vanderbilt University Medical Center. Her background is in atherosclerosis research with an emphasis on lipoprotein metabolism and macrophage cholesterol homeostasis. Her earlier studies addressed the importance of protein amphipathic helical content in reducing macrophage cholesterol burden. She further established that the macrophage trafficking of acetylated versus oxidized LDL differed resulting in impaired availability of oxidized LDL cholesterol for efflux. As an assistant member at Joseph Stokes Research Institute at Children's Hospital of Philadelphia, Dr. Yancey's research defined what cholesterol acceptor properties were relevant to mobilizing cholesterol via SR-BI and ABCA1 pathways. Since joining the faculty at Vanderbilt, her research established a cooperative interaction of exogenous apoAI and endogenous apoE in maximizing macrophage cholesterol transport via ABCA1. Her research also showed that macrophage SR-BI and apoE protect against atherosclerosis by preventing the sequestration of lysosomal cholesterol. She has extended her research efforts to focus on the role of LRP1 and SR-BI in macrophage inflammation, apoptosis, and efferocytosis. Recent research has focused on the impact of Isolevuglandins and malondialdehyde adducts on HDL cholesterol acceptor, anti-inflammatory, and anti-oxidant functions. Dr. Yancey and her team recently demonstrated that reactive dicarbonyl scavenging with 2-hydroxybenzylamine reduced atherosclerosis and improved HDL cholesterol efflux and anti-inflammatory functions.

Education

PhD - Wake Forest University, 1993

Fellowship - Biochemistry - Medical College of Pennsylvania and Hahnemann University, 1995

Fellowship - Pathology - Wake Forest University, 1999

Contact

Email 
Kimryn.Rathmell@Vumc.Org 
Address 
777 Preston Research Building 
2220 Pierce Ave 
Nashville, TN 37232-6307

Submitted by admin on Thu, 06/01/2023 - 04:28

1161 21st Ave S
Nashville, TN 37232

(615) 322-5000

Quick Links

  • Home
  • About
  • Divisions
  • Education
  • Research
  • Faculty
  • Intranet

Support Our Work

Start a fundraiser or donate to the Department of Medicine.

Give Now

Vanderbilt Health is committed to fostering an environment where everyone has the chance to thrive and is committed to the principles of equal opportunity. EOE/Vets/Disabled.

Copyright © Vanderbilt University Medical Center

sfy39587stp18